Antigen-specific Immunotherapy of Autoimmune and Allergic Diseases

Overview

Journal Curr Opin Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2010 Sep 21

PMID 20850958

Citations 75

Authors

Catherine A Sabatos-Peyton

Johan Verhagen

David C Wraith

Affiliations

Soon will be listed here.

Abstract

Nearly a century has passed since the first report describing antigen-specific immunotherapy (antigen-SIT) was published. Research into the use of antigen-SIT in the treatment of both allergic and autoimmune disease has increased dramatically since, although its mechanism of action is only slowly being unravelled. It is clear though, from recent studies, that success of antigen-SIT depends on the induction of regulatory T (T reg) cell subsets that recognise potentially disease-inducing epitopes. The major challenge remaining for the widespread use of antigen-SIT is to safely administer high doses of immunodominant and potentially pathogenic epitopes in a manner that induces T cell tolerance rather than activation. This review illustrates that intelligent design of treatment agents and strategies can lead to the development of safe and effective antigen-SIT.

Citing Articles

Graves disease: latest understanding of pathogenesis and treatment options.

Lanzolla G, Marino M, Menconi F Nat Rev Endocrinol. 2024; 20(11):647-660.

PMID: 39039206 DOI: 10.1038/s41574-024-01016-5.

Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance.

Kusumoputro S, Au C, Lam K, Park N, Hyun A, Kusumoputro E Nanomaterials (Basel). 2024; 14(1).

PMID: 38202522 PMC: 10780512. DOI: 10.3390/nano14010067.

An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis.

Au K, Wilson J, Ting J, Wang A Nat Biomed Eng. 2023; 8(10):1243-1265.

PMID: 38049469 DOI: 10.1038/s41551-023-01136-9.

Cell and biomaterial delivery strategies to induce immune tolerance.

Scotland B, Shaw J, Dharmaraj S, Caprio N, Cottingham A, Lasola J Adv Drug Deliv Rev. 2023; 203:115141.

PMID: 37980950 PMC: 10842132. DOI: 10.1016/j.addr.2023.115141.

Vaccination therapy for inflammatory bowel disease.

Liu Y, Liao F Hum Vaccin Immunother. 2023; 19(2):2259418.

PMID: 37771317 PMC: 10543345. DOI: 10.1080/21645515.2023.2259418.

References

Luth S, Huber S, Schramm C, Buch T, Zander S, Stadelmann C . Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest. 2008; 118(10):3403-10. PMC: 2542846. DOI: 10.1172/JCI32132. View

Koffeman E, Genovese M, Amox D, Keogh E, Santana E, Matteson E . Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase.... Arthritis Rheum. 2009; 60(11):3207-16. DOI: 10.1002/art.24916. View

Tisch R, Wang B, Serreze D . Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J Immunol. 1999; 163(3):1178-87. View

Garren H, Ruiz P, Watkins T, Fontoura P, Nguyen L, Estline E . Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity. 2001; 15(1):15-22. DOI: 10.1016/s1074-7613(01)00171-6. View

Ruiz P, Garren H, Ruiz I, Hirschberg D, Nguyen L, Karpuj M . Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J Immunol. 1999; 162(6):3336-41. View

Fellrath J, Kettner A, Dufour N, Frigerio C, Schneeberger D, Leimgruber A . Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial. J Allergy Clin Immunol. 2003; 111(4):854-61. DOI: 10.1067/mai.2003.1337. View

Smith P, Morris-Downes M, Heijmans N, Pryce G, Arter E, ONeill J . Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice. J Neuroimmunol. 2005; 164(1-2):76-84. DOI: 10.1016/j.jneuroim.2005.04.006. View

Gabrysova L, Wraith D . Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur J Immunol. 2010; 40(5):1386-95. PMC: 3466465. DOI: 10.1002/eji.200940151. View

Miller S, Turley D, Podojil J . Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol. 2007; 7(9):665-77. DOI: 10.1038/nri2153. View

10.

Thrower S, James L, Hall W, Green K, Arif S, Allen J . Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study. Clin Exp Immunol. 2008; 155(2):156-65. PMC: 2675245. DOI: 10.1111/j.1365-2249.2008.03814.x. View

11.

Jankovic D, Kugler D, Sher A . IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 2010; 3(3):239-46. PMC: 4105209. DOI: 10.1038/mi.2010.8. View

12.

Silver P, Agarwal R, Su S, Suffia I, Grajewski R, Luger D . Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells. J Immunol. 2007; 179(8):5146-58. PMC: 2761821. DOI: 10.4049/jimmunol.179.8.5146. View

13.

Miller A, Lider O, Weiner H . Antigen-driven bystander suppression after oral administration of antigens. J Exp Med. 1991; 174(4):791-8. PMC: 2118953. DOI: 10.1084/jem.174.4.791. View

14.

Sinha S, Subramanian S, Miller L, Proctor T, Roberts C, Burrows G . Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand. J Neurosci. 2009; 29(12):3816-23. PMC: 2705654. DOI: 10.1523/JNEUROSCI.5812-08.2009. View

15.

Ebner C, Schenk S, Najafian N, Siemann U, Steiner R, Fischer G . Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol. 1995; 154(4):1932-40. View

16.

Saraiva M, OGarra A . The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010; 10(3):170-81. DOI: 10.1038/nri2711. View

17.

Ho P, Fontoura P, Ruiz P, Steinman L, Garren H . An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems. J Immunol. 2003; 171(9):4920-6. DOI: 10.4049/jimmunol.171.9.4920. View

18.

Vanderlugt C, Miller S . Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol. 2002; 2(2):85-95. DOI: 10.1038/nri724. View

19.

Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R . Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004; 199(11):1567-75. PMC: 2211782. DOI: 10.1084/jem.20032058. View

20.

Gadermaier E, Flicker S, Aberer W, Egger C, Reider N, Focke M . Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide. Int Arch Allergy Immunol. 2009; 151(1):17-27. DOI: 10.1159/000232567. View